HARBIN, China, Oct. 14 /PRNewswire-Asia-FirstCall/ — China Sky
One Medical, Inc. (“China Sky One Medical” or “the Company”)
(Nasdaq:
CSKI), a leading fully integrated pharmaceutical company
producing over-the-counter drugs in the People’s Republic of China
(“PRC”), today announced that it held its 2010 Annual Meeting of
Stockholders (the ”Annual Meeting”) on October 12, 2010, in
Harbin, PRC.
At the Annual Meeting, the Company’s stockholders were asked to
vote on a proposal to elect seven directors to serve until the
Company’s 2011 Annual Meeting of Stockholders, or until such time
as their respective successors are elected and qualified. The
stockholders re-elected Mr. Yan-qing Liu, Ms. Xiao-yan Han, Mr.
Yu-bo Hao, Mr. Chun-fang Song, Ms. Xu-feng Qian, Mr. Jie Zhao, and
Mr. William Wei Lee as members of the Board of Directors of the
Company by a plurality of the votes cast.
About China Sky One Medical, Inc. China Sky One Medical,
Inc., a Nevada corporation, is a holding company. The Company
engages in the manufacturing, marketing and distribution of
pharmaceutical, medicinal and diagnostic products. Through its
wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and
Technology Company, Harbin First Bio-Engineering Company Limited,
Heilongjiang Tianlong Pharmaceutical, Inc. and Peng Lai Jin Chuang
Pharmaceutical Company, the Company manufactures and distributes
over-the-counter pharmaceutical products, which make up its major
revenue source. For more information, visit http://www.cski.com.cn.Investor
Relations Contact:China Sky One MedicalYan-qing Liu, CEOEmail:
ir@cski.com.cnCCG Investor RelationsCrocker Coulson,
PresidentTel: +1-646-213-1915Email:
crocker.coulson@ccgir.comWebsite: www.ccgirasia.comMabel Zhang,
Vice PresidentTel: +1-3
‘/>”/>
SOURCE